S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Start Premium Trial||Register For Free|
|P||F||Fund Financial Data (13,000+ funds)|
|P||F||Stock Financial Data (7,000+ stocks)|
|P||F||Stock and Fund Screeners (basic)|
|P||F||Investing Articles and Market Commentary|
|P||F||Articles Archive (>30 days)|
|P||F||Discuss (dozens of stock, fund, bond, and general bulletin boards)|
|P||F||Portfolio Manager (basic)|
|P||F||Morningstar Investment Classroom|
|P||F||Access Your Portfolio Anytime, Anywhere via Your Mobile Device|
|P||Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)|
|P||Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)|
|P||Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)|
|P||Portfolio Monitor (monthly and on-demand personalized portfolio statements)|
|P||Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)|
|P||Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters|
|P||Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)|
|P||Discounts on Morningstar newsletters, books, seminars, and more|
Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.
Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.
|Raging Capital Management Supports Vote "FOR" Election of BlueMountain Capital's External Director Nominees at Taro Pharmaceutical Annual General Meeting of Shareholders ()|
|Glass Lewis Recommends Taro Shareholders Vote for the Two Incumbent External Directors ()|
|BlueMountain Capital Management Announces that ISS Recommends Taro Pharmaceutical Shareholders Vote FOR the BlueMountain External Director Nominees at Upcoming Annual General Meeting (2013/9/3)|
|Taro Provides Results for Quarter Ended June 2013 (2013/8/7)|
|IsZo Capital Urges Taro Board to Withdraw its Recommendation for the Re-Election of the Current Taro External Directors at 2013 Annual Shareholder Meeting; Supports Election of BlueMountain's Independent Nominees ()|
|Taro to Defer Annual General Meeting to September 12, 2013 ()|
|BlueMountain Capital Management and IsZo Capital File Lawsuit Against Taro Pharmaceutical Industries Ltd. to Revoke the Results of the September 12, 2013 General Meeting (2013/11/21)|
|Taro to Announce Results for Quarter Ended June 30, 2013 ()|
|Taro Announces Results of Its Annual General Meeting of Shareholders (2013/9/13)|
|Taro Provides Results for September 30, 2013 (2013/11/12)|
Click above to view more mutual fund data and stats for taro - Taro Pharmaceutical Industries Ltd.